» Articles » PMID: 37583089

Initial Cancer Treatment in Certified Versus Non-Certified Hospitals

Abstract

Background: According to the National Cancer Plan in Germany, all cancer patients should receive high-quality care in accordance with evidence-based treatment guidelines. Certification programs were established for this purpose but have not yet been comprehensively evaluated.

Methods: In the WiZen project, which was supported by the Innovation Fund (supported project number 01VSF17020), controlled cohort studies were performed to investigate whether initial treatment in hospitals with or without a certificate from the German Cancer Society was associated with a difference in overall survival (primary endpoint) in patients with cancer of the colon, rectum, lung, pancreas, breast, cervix, prostate, endometrium, and ovary, head and neck cancer, and neuro-oncological tumors. The studies were based on nationwide data from adult insurees of the AOK statutory health insurance carrier for the years 2009-2017.

Results: The majority of patients with all entities except breast cancer received their initial treatment in non-certified hospitals. Initial treatment in a certified hospital was found to be beneficial in terms of overall survival for all cancer entities, even after extensive adjustment for patient- and hospital-related confounders. The hazard ratio (HR) ranged from 0.97 (95% CI: [0.94; 1.00]) for lung cancer to 0.77 [0.74; 0.81] for breast cancer, corresponding to an absolute risk reduction (ARR) for overall survival of 0.62 months for lung cancer to 4.61 months for cervical cancer.

Conclusion: The WiZen study shows for the entities studied that initial cancer treatment in a certified center is associated with lower mortality. Despite the recommendations of the National Cancer Plan, however, more than 40% of all cancer patients still receive their initial treatment in a non-certified hospital. The preferential provision of initial care in certified hospitals would be likely to improve overall survival. Although the study design does not permit any conclusion with regard to causality, the findings seem robust considering that a control group was used, confounders were taken into account, and the study population was of large size.

Citing Articles

Treatment Quality of Rectal Cancer Patients in Certified Colorectal Cancer Centers Versus Non-Certified Hospitals: A Comparative Analysis.

Mroczkowski P, Kusian H, Jannasch O, Lippert H, Zajdel R, Zajdel K Cancers (Basel). 2025; 17(1.

PMID: 39796747 PMC: 11720547. DOI: 10.3390/cancers17010120.


Course of Mental Disorders in Early Cancer Survivorship in Relation to Socioeconomic Status: A Multi-Center Prospective Longitudinal Study (LUPE).

Springer F, Goerling U, Zimmermann T, Ernst J, Engel C, Hermann M Psychooncology. 2025; 34(1):e70059.

PMID: 39780021 PMC: 11711303. DOI: 10.1002/pon.70059.


Multidisciplinary tumor boards in oral cavity cancer: survival effect due to balancing guideline adherence and treatment delays.

Burkhardt V, El-Shabrawi K, Riemann S, Voss P, Becker C Front Oral Health. 2024; 5:1493319.

PMID: 39620063 PMC: 11604625. DOI: 10.3389/froh.2024.1493319.


Quality-assured treatment in certified cancer center networks in upper Franconia, Germany: a population-centered retrospective cohort analysis based on data of the Bavarian cancer registry.

Emmert M, Gorodiscan I, Thater A, Buchner D, Kiani A, Muller-Nordhorn J BMC Health Serv Res. 2024; 24(1):1453.

PMID: 39578869 PMC: 11583377. DOI: 10.1186/s12913-024-11972-3.


Patient management with Head and Neck tumors-A nationwide data collection in oral and maxillofacial surgery.

Pabst A, Zeller A, Goetze E, Holzle F, Hoffmann J, Raguse J Clin Oral Investig. 2024; 28(9):469.

PMID: 39105887 DOI: 10.1007/s00784-024-05859-0.


References
1.
Trautmann F, Reissfelder C, Pecqueux M, Weitz J, Schmitt J . Evidence-based quality standards improve prognosis in colon cancer care. Eur J Surg Oncol. 2018; 44(9):1324-1330. DOI: 10.1016/j.ejso.2018.05.013. View

2.
Chioreso C, Del Vecchio N, Schweizer M, Schlichting J, Gribovskaja-Rupp I, Charlton M . Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis. Dis Colon Rectum. 2018; 61(11):1320-1332. PMC: 7000208. DOI: 10.1097/DCR.0000000000001198. View

3.
Volkel V, Draeger T, Gerken M, Furst A, Klinkhammer-Schalke M . [Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]. Gesundheitswesen. 2018; 81(10):801-807. DOI: 10.1055/a-0591-3827. View

4.
Balan T, Putter H . A tutorial on frailty models. Stat Methods Med Res. 2020; 29(11):3424-3454. PMC: 7534210. DOI: 10.1177/0962280220921889. View

5.
Roessler M, Schmitt J, Bobeth C, Gerken M, Tol K, Reissfelder C . Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer. 2022; 22(1):621. PMC: 9172168. DOI: 10.1186/s12885-022-09731-w. View